Ledger.Open graph →
SEC Form D · filed February 13, 2014

BIO BLAST PHARMA LTD

Offering
$4.8M
Sold
$4.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TEL AVIV, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Dalia Megiddo · TEL AVIV, L3Exec · DirectorMarlene Haffner · TEL AVIV, L3DirectorYaron Daniely · TEL AVIV, L3DirectorUdi Gilboa · TEL AVIV, L3Exec · DirectorFredric Price · London, United KingdomDirectorRan Nusbaum · TEL AVIV, L3DirectorMarlene Haffner · TEL AVIV, L3DirectorYaron Daniely · TEL AVIV, L3DirectorDalia Megiddo · Fremont, CAExec · DirectorUdi Gilboa · TEL AVIV, L3Exec · DirectorFredric Price · TEL AVIV, L3DirectorRan Nusbaum · TEL AVIV, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗